Interferon-γ and tumor necrosis factor-α differentially affect cytokine expression and migration properties of mesenchymal stem cells

Stem Cells and Development

Volumn 19, Issue 5, 2010, Pages 693-706

  Hemeda, Hatim ^a   Jakob, Mark ^a   Ludwig, Anna Kristin ^b   Giebel, Bernd ^b   Lang, Stephan ^a   Brandau, Sven ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR10; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR3; CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CCR6; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CCR8; CHEMOKINE RECEPTOR CCR9; CHEMOKINE RECEPTOR CXCR1; CHEMOKINE RECEPTOR CXCR2; CHEMOKINE RECEPTOR CXCR3; CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR5; CHEMOKINE RECEPTOR CXCR6; CHEMOKINE RECEPTOR CXCR7; CYTOKINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ADIPOCYTE; ARTICLE; CARTILAGE CELL; CELL ADHESION; CELL DIFFERENTIATION; CELL HOMING; CELL IMMORTALIZATION; CELL MIGRATION; CELL STIMULATION; CELL TYPE; CONTROLLED STUDY; CYTOKINE RELEASE; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IMMUNOMODULATION; LYMPHOCYTE PROLIFERATION; MESENCHYMAL STEM CELL; MULTIPOTENT STEM CELL; OSTEOCYTE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; UMBILICAL CORD BLOOD; BIOSYNTHESIS; BONE MARROW CELL; CELL CULTURE; CELL MOTION; CELL PROLIFERATION; CYTOLOGY; DRUG EFFECTS; FETUS BLOOD; GENE EXPRESSION REGULATION; GENETICS; LYMPHOCYTE; MESENCHYMAL STROMA CELL; METABOLISM;

BONE MARROW CELLS; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; CYTOKINES; FETAL BLOOD; GENE EXPRESSION REGULATION; HUMANS; INTERFERON-GAMMA; LYMPHOCYTES; MESENCHYMAL STEM CELLS; TUMOR NECROSIS FACTOR-ALPHA; MESENCHYMAL STROMAL CELLS;

EID: 77952944054     PISSN: 15473287     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.2009.0365     Document Type: Article

References (48)

1. Friedenstein AJ, JF Gorskaja and NN Kulagina. (1976). Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol 4:267-274.
2. Pittenger MF, AM Mackay, SC Beck, RK Jaiswal, R Douglas, JD Mosca, MA Moorman, DW Simonetti, S Craig and DR Marshak. (1999). Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147.
3. Wakitani S, T Saito and AI Caplan. (1995). Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine. Muscle Nerve 18:1417-1426.
4. Woodbury D, EJ Schwarz, DJ Prockop and IB Black. (2000). Adult rat and human bone marrow stromal cells differentiate into neurons. J Neurosci Res 61:364-370.
5. Reyes M, T Lund, T Lenvik, D Aguiar, L Koodie and CM Verfaillie. (2001). Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. Blood 98:2615-2625
6. Horwitz EM, K Le Blanc, M Dominici, I Mueller, I Slaper-Cortenbach, FC Marini, RJ Deans, DS Krause and A Keating; the International Society for Cellular Therapy. (2005). Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Cytotherapy 7:393-395.
7. Rotter N, J Oder, P Schlenke, U Lindner, F Böhrnsen, J Kramer, J Rohwedel, R Huss, S Brandau, B Wollenberg and S Lang. (2008). Isolation and characterization of adult stem cells from human salivary glands. Stem Cells Dev 17:509-518.
8. Miao Z, J Jin, L Chen, J Zhu, W Huang, J Zhao, H Qian and X Zhang. (2006). Isolation of mesenchymal stem cells from human placenta: comparison with human bone marrow mesenchymal stem cells. Cell Biol Int 30:681-687. (Pubitemid 44331625)
9. Prockop DJ, CA Gregory and JL Spees. (2003). One strategy for cell and gene therapy: harnessing the power of adult stem cells to repair tissues. Proc Natl Acad Sci USA 100(Suppl. 1):11917-11923.
10. Nathan S, S Das De, A Thambyah, C Fen, J Goh and EH Lee. (2003). Cell-based therapy in the repair of osteochondral defects: a novel use for adipose tissue. Tissue Eng 9:733-744.
11. Chamberlain JR, U Schwarze, PR Wang, RK Hirata, KD Hankenson, JM Pace, RA Underwood, KM Song, M Sussman, PH Byers and DW Russell. (2004). Gene targeting in stem cells from individuals with osteogenesis imperfecta. Science 303:1198-1201.
12. Le Blanc K, I Rasmusson, B Sundberg, C Götherström, M Hassan, M Uzunel and O Ringdén. (2004). Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 363:1439-1441.
13. Lapidot T, A Dar and O Kollet. (2005). How do stem cells find their way home? Blood 106:1901-1910.
14. Fu S and J Liesveld. (2000). Mobilization of hematopoietic stem cells. Blood Rev 14:205-218.
15. Romagnani P, L Lasagni and S Romagnani. (2006). Peripheral blood as a source of stem cells for regenerative medicine. Expert Opin Biol Ther 6:193-202.
16. Stagg J. (2007). Immune regulation by mesenchymal stem cells: two sides to the coin. Tissue Antigens 69:1-9.
17. Xu G, L Zhang, G Ren, Z Yuan, Y Zhang, RC Zhao and Y Shi. (2007). Immunosuppressive properties of cloned bone marrow mesenchymal stem cells. Cell Res 17:240-248. (Pubitemid 46438724)
18. Aggarwal S and MF Pittenger. (2005). Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105:1815-1822.
19. Di Nicola M, C Carlo-Stella, M Magni, M Milanesi, PD Longoni, P Matteucci, S Grisanti and AM Gianni. (2002). Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 99:3838-3843.
20. Krampera M, S Glennie, J Dyson, D Scott, R Laylor, E Simpson and F Dazzi. (2003). Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood 101:3722-3729.
21. Groh ME, B Maitra, E Szekely and ON Koç. (2005). Human mesenchymal stem cells require monocyte-mediated activation to suppress alloreactive T cells. Exp Hematol 33:928-934.
22. Krampera M, L Cosmi, R Angeli, A Pasini, F Liotta, A Andreini, V Santarlasci, B Mazzinghi, G Pizzolo, F Vinante, P Romagnani, E Maggi, S Romagnani and F Annunziato. (2006). Role for interferongamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells. Stem Cells 24:386-398.
23. Nauta AJ and WE Fibbe. (2007). Immunomodulatory properties of mesenchymal stromal cells. Blood 110:3499-3506.
24. Conrad C, B Gottgens, S Kinston, J Ellwart and R Huss. (2002). GATA transcription in a small rhodamine 123 (low) CD34 (+) subpopulation of a peripheral blood-derived CD34 (-) CD105 (+) mesenchymal cell line. Exp Hematol 30:887-895.
25. Calandra T and T Roger. (2003). Macrophage migration inhibitory factor: a regulator of innate immunity. Nat Rev Immunol 3:791-800. (Pubitemid 37328657)
26. Hall B, J Dembinski, AK Sasser, M Studeny, M Andreeff and F Marini. (2007). Mesenchymal stem cells in cancer: tumor-associated fibroblasts and cell-based delivery vehicles. Int J Hematol 86:8-16.
27. Kolf CM, E Cho and RS Tuan. (2007). Mesenchymal stromal cells. Biology of adult mesenchymal stem cells: regulation of niche, self-renewal and differentiation. Arthritis Res Ther 9:204.
28. Conget PA and JJ Minguell. (1999). Phenotypical and functional properties of human bone marrow mesenchymal progenitor cells. J Cell Physiol 181:67-73.
29. Thalmeier K, P Meissner, G Reisbach, M Falk, A Brechtel and P Dörmer. (1994). Establishment of two permanent human bone marrow stromal cell lines with long-term post irradiation feeder capacity. Blood 83:1799-1807.
30. Stagg J and J Galipeau. (2007). Immune plasticity of bone marrowderived mesenchymal stromal cells. Handb Exp Pharmacol 180:45-66.
31. Bonney EA and P Matzinger. (1998). Much IDO about pregnancy. Nat Med 4:1128-1129.
32. Munn DH, M Zhou, JT Attwood, I Bondarev, SJ Conway, B Marshall, C Brown and AL Mellor. (1998). Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 281:1191-1193.
33. Ryan JM, F Barry, JM Murphy and BP Mahon. (2007). Interferongamma does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells. Clin Exp Immunol 149:353-363.
34. Le Blanc K and O Ringdén. (2007). Immunomodulation by mesenchymal stem cells and clinical experience. J Intern Med 262:509-525. (Pubitemid 47620502)
35. English K, FP Barry, CP Field-Corbett and BP Mahon. (2007). IFN-gamma and TNF-alpha differentially regulate immunomodulation by murine mesenchymal stem cells. Immunol Lett 110:91-100.
36. Moser B, M Wolf, A Walz and P Loetscher. (2004). Chemokines: multiple levels of leukocyte migration control. Trends Immunol 25:75-84.
37. Sallusto F, CR Mackay and A Lanzavecchia. (2000). The role of chemokine receptors in primary, effector, and memory immune responses. Annu Rev Immunol 18:593-620.
38. Wynn RF, CA Hart, C Corradi-Perini, L O'Neill, CA Evans, JE Wraith, LJ Fairbairn and I Bellantuono. (2004). A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow. Blood 104:2643-2645.
39. Ji JF, BP He, ST Dheen and SS Tay. (2004). Interactions of chemokines and chemokine receptors mediate the migration of mesenchymal stem cells to the impaired site in the brain after hypoglossal nerve injury. Stem Cells 22:415-427.
40. Sordi V, ML Malosio, F Marchesi, A Mercalli, R Melzi, T Giordano, N Belmonte, G Ferrari, BE Leone, F Bertuzzi, G Zerbini, P Allavena, E Bonifacio and L Piemonti. (2005). Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets. Blood 106:419-427.
41. Honczarenko M, Y Le, M Swierkowski, I Ghiran, AM Glodek and LE Silberstein. (2006). Human bone marrow stromal cells express a distinct set of biologically functional chemokine receptors. Stem Cells 24:1030-1041.
42. Pan J, EJ Kunkel, U Gosslar, N Lazarus, P Langdon, K Broadwell, MA Vierra, MC Genovese, EC Butcher and D Soler. (2000). A novel chemokine ligand for CCR10 and CCR3 expressed by epithelial cells in mucosal tissues. J Immunol 165:2943-2949.
43. Wang W, H Soto, ER Oldham, ME Buchanan, B Homey, D Catron, N Jenkins, NG Copeland, DJ Gilbert, N Nguyen, J Abrams, D Kershenovich, K Smith, T McClanahan, AP Vicari and A Zlotnik. (2000). Identification of a novel chemokine (CCL28), which binds CCR10 (GPR2). J Biol Chem 275:22313-22323.
44. Croitoru-Lamoury J, FM Lamoury, JJ Zaunders, LA Veas and BJ Brew. (2007). Human mesenchymal stem cells constitutively express chemokines and chemokine receptors that can be upregulated by cytokines, IFN-beta, and Copaxone. J Interferon Cytokine Res 27:53-64.
45. Ponte AL, E Marais, N Gallay, A Langonné, B Delorme, O Hérault, P Charbord and J Domenech. (2007). The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities. Stem Cells 25:1737-1745.
46. Studeny M, FC Marini, RE Champlin, C Zompetta, IJ Fidler and M Andreeff. (2002). Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors. Cancer Res 62:3603-3608.
47. Chan J, K O'Donoghue, J de la Fuente, IA Roberts, S Kumar, JE Morgan and NM Fisk. (2005). Human fetal mesenchymal stem cells as vehicles for gene delivery. Stem Cells 23:93-102.
48. Kaspar BK. (2008). Mesenchymal stem cells as troj an horses for GDNF delivery in ALS. Mol Ther 16:1905-1906.